black cohosh

Pharmaceutical company spends millions studying how to steal black cohosh component as potential treatment for Alzheimer's

Wednesday, April 18, 2012 by: Jonathan Benson, staff writer
Tags: black cohosh, Alzheimer's, drug industry

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
10 other companies that use the same Subway yoga mat chemical in their buns
High-dose vitamin C injections shown to annihilate cancer
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Battle for humanity nearly lost: global food supply deliberately engineered to end life, not nourish it
Diet soda, aspartame linked to premature deaths in women
Cannabis kicks Lyme disease to the curb
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Harvard research links fluoridated water to ADHD, mental disorders
Right to farm being stripped from Americans: Michigan to criminalize small family farms with chickens, goats, honey bees and more
Delicious
(NaturalNews) In the push to develop new drugs to treat Alzheimer's disease, drug company Satori Pharmaceuticals has successfully raised $37 million in venture capital to continue studying a key compound that it believes will eventually lead to a major breakthrough in disease treatment. And according to Xconomy.com, this compound comes from natural black cohosh, a perennial plant whose extract is often used to treat menopause symptoms.

Unbeknownst to many people today is the fact that pharmaceutical drugs are largely derived from natural herbs and plants that have been chemically synthesized into patented, isolated drug formulas. And Satori's approach with black cohosh is no different, as the company hopes to eventually conduct human clinical trials on an isolated, synthesized version of the compound in question to verify that it actually does target amyloid beta 42, the protein that many researchers believe is connected with Alzheimer's development.

Buildup of beta amyloid proteins in the brain is a hallmark of Alzheimer's disease, as this process is believed to degrade nerve cells in the brain and block proper nerve function. And when secretases, which are enzymes that promote the production of beta amyloid proteins, begin to dysfunction, the body is unable to successfully break them apart and prevent them from lodging in the brain.

But the substance identified in black cohosh, which was the result of work being done at the Mayo Clinic, reportedly binds with a specific enzyme known as gamma secretase that promotes the production of beta amyloid proteins, and stops them from forming in the brain. And unlike previous secretase inhibitor drugs that blocked all amyloid-promoting enzymes, including those that performed beneficial functions, natural black cohosh appears to block just those that are harmful while leaving the others alone.

"The molecule found at Mayo is a minor constituent of black cohosh that modulates gamma secretase," said Jeff Ives, CEO of Satori, concerning the findings. "It's a unique chemical series."

As good as this news is, however, it is important to note that Satori does not necessarily plan to utilize black cohosh extract in its natural form for treatment -- the company will likely break it apart, patent it, and sell it as an FDA-approved drug in the future. And as we all know, whenever a natural substance is artificially synthesized and separated from its other natural cofactors, negative side effects emerge.

On the other hand, it would appear as though taking black cohosh extract as it is currently available might be an effective way to prevent or even mitigate Alzheimer's symptoms without the need for an actual drug.

Sources for this article include:

http://www.xconomy.com

http://www.rxalternativemedicine.com/articles/dementia.html

http://www.naturalnews.com/black_cohosh.html

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.